Web Sify
Follow us on
Sify.com » Topics » Use
Use News

Jentadueto™ (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with Type 2 Diabetes in Europe
Ingelheim, Germany: Boehringer Ingelheim and Eli Lilly and Company has announced that they have received a positive opinion from the European Medicines Agency’s (EMA) medicinal committee recommending approval of Jentadueto™, which combines the DPP-4 inhibitor, linagliptin (the active ingredient in Trajenta tablets) and metformin in a single tablet.1 If
Use Galleries
Use Videos
The Situation treated for drug... The Situation treated for drug...
The Situation treated for drug use
Hilton denies cocaine was hers Hilton denies cocaine was hers
Hilton denies cocaine was hers
Govt will be able to contain M... Govt will be able to contain M...
Govt will be able to contain Maoist menace: Chidambaram
Bieber concert canceled  Bieber concert canceled 
Bieber concert canceled